Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami.

Cell Journal [Yakhteh]. 2016; 18 (3): 302-309

Dans Anglais | IMEMR | ID: emr-183764

ABSTRACT

ABSTRACT

Objective:

nonunion is defined as a minimum of 9 months since injury without any visible progressive signs of healing for 3 months. Recent literature has shown that the application of mesenchymal stromal cells is safe, in vitro and in vivo, for treating long bone nonunion. The present study was performed to investigate the safety of mesenchymal stromal cell [MSC] implantation in combination with platelet lysate [PL] product for treating human long bone nonunion

Recherche sur Google

Imprimer

XML

Indice: Méditerranée orientale Type d'étude: Essai clinique contrôlé langue: Anglais Texte intégral: Cell J. [Yakhteh] Année: 2016

Documents relatifs à ce sujet

MEDLINE

LILACS

LIS

Recherche sur Google

Imprimer

XML

Indice: Méditerranée orientale Type d'étude: Essai clinique contrôlé langue: Anglais Texte intégral: Cell J. [Yakhteh] Année: 2016